Lactosylceramides Analysis Service

Overview Challenges & Solutions Services Applications Workflow Samples Outputs Data Products FAQs
LacCer-Centered GSL Analysis

LC-MS/MS-Based Lactosylceramide Profiling and Quantification

Creative Biolabs provides research-use lactosylceramides analysis services for profiling and quantifying LacCer molecular species in cells, tissues, serum, plasma, and lipid extracts. As part of our GSL analysis capabilities, this service helps researchers evaluate LacCer as a pathway node connecting glucosylceramide/HexCer metabolism with downstream neutral and acidic GSL branches, including globo-, ganglio-, lacto-, and neolacto-series structures.

LacCer Analysis LC-MS/MS GSL Panels Species Profiling RUO

Project Fit

  • Standalone LacCer analysis for research screening or treatment comparison.
  • Custom LacCer profiling with adjacent GlcCer/HexCer, Gb3, GA2, and ganglioside nodes.
  • Pathway-context interpretation that avoids overstating enzyme activity or disease conclusions.

Why Lactosylceramide Is a Useful GSL Pathway Node

Lactosylceramide (LacCer; Galβ1-4Glcβ-Cer) is produced from glucosylceramide and provides a common precursor pool for multiple downstream glycosphingolipid families. In membrane biology, inflammation, differentiation, immune-cell activation, and sphingolipid metabolism studies, LacCer measurements can help place an observed lipid change into a broader pathway context.

Because LacCer lies between the GlcCer/HexCer node and higher-order GSLs, LacCer profiling can help researchers assess whether early glycosylceramide remodeling is accompanied by downstream GSL changes. LacCer abundance alone, however, should not be treated as a direct readout of one specific enzyme without appropriate substrates, products, controls, and complementary assays.

  • LacCer connects early glycosylceramide metabolism with downstream neutral and sialylated GSL branches.
  • LacCer analysis supports research comparisons involving treatments, genotypes, differentiation states, immune activation, or time courses.
  • Species-level profiles help distinguish a focused LacCer shift from broader remodeling across related GSL classes.
Fig.1 Lactosylceramide structure. (Creative Biolabs Authorized)

Fig.1 Lactosylceramide structure.

Analytical Challenges in Lactosylceramide Profiling and Solutions

Reliable lactosylceramide analysis must address low-abundance species, matrix effects, ceramide backbone heterogeneity, possible co-elution with related neutral GSLs, and limited availability of matched standards for every molecular species. These factors influence annotation confidence, quantification strategy, and cross-sample comparability.

Low Abundance

Minor LacCer species can be difficult to measure when sample input is limited or matrix background is high.

Isomer and Class Context

GlcCer/GalCer and related GSLs may need chromatographic separation or careful panel design for confident interpretation.

Backbone Diversity

Fatty acyl chain length, saturation, hydroxylation, and sphingoid-base variation can affect retention and signal response.

Interpretation Limits

A LacCer shift is best interpreted with study context, adjacent pathway nodes, and appropriate biological controls.

Targeted LC-MS/MS

MRM-based acquisition can support sensitive relative or standard-supported quantification of predefined LacCer species.

HRMS/MS Profiling

Accurate-mass and MS/MS-supported profiling can be considered for exploratory or annotation-focused projects.

Custom Separation

HILIC, RP-LC, or project-specific LC conditions can be selected according to class coverage and target-panel needs.

Pathway Context

GlcCer/HexCer, Gb3, Gb4, GA2, and ganglioside readouts can be added when broader GSL interpretation is needed.

LacCer abundance should not be used as a direct surrogate for one enzyme activity or a diagnostic conclusion. For enzyme-focused projects, LacCer results should be interpreted with substrate/product patterns, controls, and complementary assays.

Our Lactosylceramides Analysis Services

Creative Biolabs offers lactosylceramide identification and quantification service options for focused LacCer projects and pathway-integrated GSL studies. Each project can be configured by matrix type, sample number, target species, available standards, and preferred quantification mode.

Targeted LacCer Quantification

Relative quantification or standard-supported absolute quantification for predefined LacCer molecular species.

Molecular Species Profiling

Comparison of LacCer species by ceramide backbone, including chain length, saturation, and hydroxylation where supported by the method.

Comparative Analysis

Group comparison for treatment, genotype, time-course, differentiation, stimulation, or cell-state studies.

LacCer-Centered GSL Panels

Optional integration with GlcCer/HexCer, Gb3, Gb4, GA2, gangliosides, and selected sphingolipid nodes.

What Problems Our LacCer Analysis Helps Researchers Solve

Researchers often need to know whether LacCer changes under treatment, genotype, differentiation, inflammatory stimulation, immune-cell activation, or metabolic-enzyme study conditions. LC-MS/MS-based LacCer analysis can help clarify whether the observed signal appears isolated, is linked to upstream GlcCer/HexCer changes, or is accompanied by downstream GSL remodeling.

Screening Readout

Use LacCer as an initial research readout before expanding into a larger glycolipid panel.

  • Treatment comparison
  • Cell membrane research
  • Time-course studies

Pathway Interpretation

Connect LacCer shifts with upstream and downstream GSL species when a broader panel is included.

  • GlcCer/HexCer remodeling
  • Downstream conversion patterns
  • Complex GSL remodeling

Enzyme Hypotheses

Generate pathway hypotheses that can guide follow-up enzyme or functional assays.

  • Substrate/product patterns
  • Comparative controls
  • Complementary assay planning

Recommended Workflow for Lactosylceramides Analysis

Our lactosylceramide profiling workflow is structured for standalone LacCer quantification, targeted LacCer-centered panels, or broader multi-class LC-MS/MS analysis when pathway interpretation is needed.

Fig.2 Lactosylceramide profiling workflow overview. (Creative Biolabs Original)

Fig.2 Lactosylceramide profiling workflow overview.

1

Objective

Define standalone LacCer analysis or a LacCer-centered GSL panel.

2

Matrix Review

Review matrix, sample amount, abundance expectations, and related GSL targets.

3

Extraction

Apply lipid extraction and cleanup procedures suitable for LacCer and selected GSL classes.

4

LC-MS/MS

Acquire targeted LC-MS/MS data or HRMS/MS-supported profiling data according to project scope.

5

Reporting

Deliver data tables, QC notes, method details, and a restrained pathway-context summary.

Request a Quote

Sample Types We Can Support

Creative Biolabs supports research-use LacCer analysis for cultured cells, tissues, serum, plasma, lipid extracts, and enriched GSL fractions. Other biofluids or disease-model samples can be reviewed for feasibility based on matrix complexity, available amount, and target-panel design. For best planning, please share sample matrix, storage condition, target pathway, group design, and any existing upstream or downstream lipid data.

Sample Handling Notes

LacCer and related GSL measurements are sensitive to matrix effects, extraction efficiency, and storage history. We recommend consistent collection, rapid freezing when appropriate, avoidance of repeated freeze-thaw cycles, and matched handling across comparison groups.

  • Cells, tissues, serum, plasma, lipid extracts, or enriched GSL fractions
  • Feasibility review for other research matrices
  • Matched handling across all groups whenever possible

Suggested Submission Information

  • Sample matrix, storage condition, and available amount.
  • Project objective and group comparison logic.
  • Target LacCer species or broader GSL panel.
  • Existing ceramide, GlcCer/HexCer, globoside, GA2, or ganglioside data.
  • Preferred relative, standard-supported absolute, or screening-first analysis.

Deliverables and Data Outputs

Our deliverables are designed to support transparent data review and follow-on study planning. For pathway-focused projects, the report can include an upstream/downstream pattern summary while clearly separating measured results from biological hypotheses.

Typical Deliverables

  • LacCer species abundance table and group comparison.
  • Retention time, ion transition, and annotation-confidence notes where applicable.
  • Internal-standard information and quantification approach.
  • QC summary, matrix notes, and a technical report for research interpretation.

How Results Are Interpreted

We help clients read LacCer changes in the context of study design and related GSL nodes. The report can highlight patterns consistent with broader pathway remodeling, but it will not claim enzyme activity, diagnosis, or therapeutic effect without direct supporting assays.

  • Measured data are separated from interpretation.
  • Standard availability is stated for absolute quantification.
  • Follow-up assays can be recommended when needed.

Start a Lactosylceramides Analysis Project

To begin a custom LacCer profiling service, please provide sample type, objective, sample number, target LacCer species, related GSLs, and preferred quantification mode. We will recommend a feasible analysis plan based on your research question and available material.

Request a Quote Review Products

Published Data Supporting LacCer-Centered GSL Profiling

Published LC-MS/MS studies support the use of LacCer as one node within targeted GSL panels rather than as a standalone mechanistic conclusion. The open-access study cited below developed a multiplexed targeted LC-MS/MS method for serum gangliosides and glycosphingolipids, including GlcCer, LacCer, Gb3, GA2, and multiple ganglioside classes. This supports the analytical logic of placing LacCer next to adjacent pathway nodes in research-use panel design.

Fig.3 Glycosphingolipid pathway showing LacCer, GlcCer, Gb3, GA2, and ganglioside-related nodes. (OA Literature)

Fig.3 Glycosphingolipid pathway context for LacCer.1

Customer Review

Recommended Products

These research-use product categories may support glycan-focused assay development, method setup, and related glycoanalysis projects. Product suitability depends on the assay format, target glycoepitope, and intended research application.

Hot Products

Carbohydrate Antigen Products

Research-use carbohydrate antigens for glycan-focused assay design and analytical method support.

Learn More
mAbs

Monoclonal Antibody Products

Monoclonal antibody products for selected glycoepitope-recognition and detection research assays.

Learn More
pAbs

Polyclonal Antibody Products

Polyclonal antibody products for selected glycoantigen detection and assay-support workflows.

Learn More

Frequently Asked Questions

Lactosylceramide is a glycosphingolipid that links glucosylceramide metabolism with downstream complex GSL branches. Measuring LacCer can help researchers place lipid changes into a broader pathway context.
We support targeted LC-MS/MS quantification, project-dependent HRMS/MS-supported profiling, HILIC or RP-LC separation strategies, and LacCer-centered multi-class GSL panels.
Absolute quantification can be discussed when suitable standards and calibration strategy are available. Relative quantification is available for comparison and screening projects.
Yes. LacCer can be integrated with GlcCer/HexCer, Gb3, Gb4, GA2, gangliosides, and selected sphingolipid nodes, depending on project objectives and method feasibility.
No. LacCer shifts can support a pathway hypothesis, but enzyme activity or mechanism should be assessed with proper controls and complementary assays.
Please provide sample type, storage condition, group design, sample number, target species, related GSLs, and preferred quantification mode.

References

1
Kim, Jinyong, Seul Kee Byeon, Devin Oglesbee, Matthew J. Schultz, Dietrich Matern, and Akhilesh Pandey. "A multiplexed targeted method for profiling of serum gangliosides and glycosphingolipids: application to GM2-gangliosidosis." Analytical and Bioanalytical Chemistry 416 (2024): 5689-5699. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1007/s00216-024-05487-3
For Research Use Only. Not For Clinical Use.
Loading case studies...
Copyright © 2026 Creative Biolabs. All Rights Reserved.